A typical mid-size cardiac EP clinic in 2026 does not have a single ICM patient population. It has three — one for each major device manufacturer — and managing them means logging into three separate web platforms, learning three different interface paradigms, and exporting data in three different formats when the cardiologist asks for a summary. This is not a niche operational problem. It is the default state for any clinic that has been implanting ICMs over the past five to eight years, as the Abbott Confirm Rx, Medtronic LINQ II, and Biotronik BioMonitor have each captured portions of the implant population depending on physician preference and hospital contracts.
Merlin.net is Abbott's web-based remote monitoring portal for the Confirm Rx. Transmissions come in via Bluetooth from the patient's smartphone using the Abbott app, and the platform presents arrhythmia summaries with Abbott's proprietary classification labels. The interface is organized around episode type with thumbnail EGM strips. CareLink is Medtronic's equivalent for the LINQ II and older Reveal LINQ devices. It offers a different visual layout, uses Medtronic's classification terminology, and delivers transmissions via the MyCareLink Smart cellular hub or mobile app. Biotronik's Home Monitoring Service (HMS) covers the BioMonitor 2 and BioMonitor 3, transmitting nightly via the CardioMessenger Smart device and presenting data through the Biotronik web portal with its own display conventions.
None of these platforms was designed to work alongside the others. Each represents a complete monitoring ecosystem built around a single manufacturer's device family. When a clinic has patients on all three, the device coordinator's morning review involves opening three separate browser tabs, authenticating into three systems, and running through three queues that present clinically similar information in three incompatible ways.
Beyond interface differences, the platforms use different classification labels for what are often clinically equivalent findings. What Merlin.net calls a "High Ventricular Rate" episode may correspond to what CareLink classifies as an "RR Irregularity" or what HMS flags as a "Ventricular Rate Episode." The underlying EGM may show the same morphology. The coordinator reviewing across platforms needs to mentally translate between terminologies to maintain a consistent clinical standard.
This translation burden is low-stakes for experienced coordinators who have worked with all three systems for years. It becomes higher-stakes for newer staff, for cross-coverage situations when a covering coordinator is less familiar with a specific platform, and for any downstream reporting that aggregates findings across the patient population. An internal review of how many total AF burden episodes exceeded a given threshold in the past quarter becomes a manual reconciliation exercise when the source data lives in three platforms with different time windows, different burden calculation methods, and different export formats.
When a clinical event requires documentation in the EHR, the coordinator typically downloads a PDF report from the originating platform and attaches it to the encounter. Merlin.net, CareLink, and HMS each produce PDFs with different layouts, different summary statistics, and different levels of EGM detail. The cardiologist reviewing the attachment on a follow-up visit needs to be able to quickly locate the AF burden percentage, the longest pause duration, and the episode timestamps — information that appears in different sections depending on which PDF they are looking at.
Epic's Cardiac Device Module and Cerner Millennium Cardiology both support structured data import from remote monitoring platforms, but the implementation status and data completeness varies by platform and site-specific configuration. Clinics that have completed full integration between one manufacturer's platform and their EHR frequently find that the integration does not extend cleanly to the other two manufacturers' data, leaving the coordinator to handle two of three platforms through manual PDF workflows even after significant integration investment.
Remote monitoring platforms send alert notifications to the clinic based on device-programmed thresholds. These notifications arrive as emails or SMS messages, depending on how the clinic configured its account. When a clinic receives an alert notification, identifying which patient the alert belongs to, which platform it came from, and whether a coordinator has already reviewed it requires checking the platform directly — there is no unified notification inbox across manufacturers.
In a small clinic with one device coordinator, this is a minor inconvenience. In a larger practice with two or three coordinators who share coverage responsibilities, the absence of a unified view creates coordination overhead. A high-rate episode alert that arrives on a Friday afternoon may sit unacknowledged until Monday if the on-call coordinator does not actively check all three platforms.
The value of an analytics layer that integrates across Merlin.net, CareLink, and HMS is not in replacing those platforms. Manufacturer platforms handle the device communication, automatic scheduling, and compliance reporting that clinics are contractually and operationally dependent on. The value is in providing a single clinical review interface that normalizes the data from all three into consistent terminology, a unified queue sorted by clinical priority rather than platform origin, and structured output that maps to the clinic's EHR fields.
Implansense connects to all three manufacturer platforms and presents the coordinator with a normalized transmission queue. A LINQ II transmission and a Confirm Rx transmission from the same morning appear in the same list, sorted by the same risk-stratification logic, with findings described in consistent clinical language. When the coordinator opens a transmission detail view, they see Implansense's classification alongside the original manufacturer label and the source EGM, so no information is hidden or overridden. The coordinator reviews once, in one place, and the summary maps to the EHR structure their practice uses.
For clinics managing 150 or more ICM patients across multiple device brands, the reduction in platform-switching overhead is measurable. More importantly, the unified queue enables consistent clinical prioritization regardless of which manufacturer made the device that transmitted.
